Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 3/2024

03-01-2024 | SARS-CoV-2 | LETTER TO THE EDITOR

Acute liver injury after SARS-CoV-2 vaccination and luspatercept administration in a patient with β-thalassemia

Authors: Simona Leoni, Rayan Bou-Fakhredin, Francesca Granata, Elena Cassinerio, Marco Maggioni, Anna Ludovica Fracanzani, Maria Domenica Cappellini, Irene Motta

Published in: Annals of Hematology | Issue 3/2024

Login to get access

Excerpt

Dear Editor, …
Appendix
Available only for authorised users
Literature
1.
Codoni G, Kirchner T, Engel B, Villamil AM, Efe C, Stattermayer AF et al (2023) Histological and serological features of acute liver injury after SARS-CoV-2 vaccination. JHEP Rep 5(1):100605CrossRefPubMed
2.
Patel AH, Amin R, Lalos AT (2022) Acute liver injury and IgG4-related autoimmune pancreatitis following mRNA-based COVID-19 vaccination. Hepatol Forum 3(3):97–99PubMedPubMedCentral
3.
Wong CKH, Mak LY, Au ICH, Lai FTT, Li X, Wan EYF et al (2022) Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines. J Hepatol 77(5):1339–1348CrossRefPubMedPubMedCentral
4.
Efe C, Kulkarni AV, Terziroli Beretta-Piccoli B, Magro B, Stattermayer A, Cengiz M et al (2022) Liver injury after SARS-CoV-2 vaccination: features of immune-mediated hepatitis, role of corticosteroid therapy and outcome. Hepatology 76(6):1576–1586CrossRefPubMed
5.
Bril F, Al Diffalha S, Dean M, Fettig DM (2021) Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty? J Hepatol 75(1):222–224CrossRefPubMedPubMedCentral
6.
Kulkarni AV, Anders M, Nazal L, Ridruejo E, Efe C (2023) Cases of severe acute liver injury following inactivated SARS-CoV-2 vaccination. J Hepatol 78(2):e60–e61CrossRefPubMed
7.
Shroff H, Satapathy SK, Crawford JM, Todd NJ, VanWagner LB (2022) Liver injury following SARS-CoV-2 vaccination: a multicenter case series. J Hepatol 76(1):211–214CrossRefPubMed
8.
Cappellini MD, Viprakasit V, Taher AT, Georgiev P, Kuo KHM, Coates T et al (2020) A phase 3 trial of luspatercept in patients with transfusion-dependent β-thalassemia. N Engl J Med 382(13):1219–1231CrossRefPubMed
Metadata
Title
Acute liver injury after SARS-CoV-2 vaccination and luspatercept administration in a patient with β-thalassemia
Authors
Simona Leoni
Rayan Bou-Fakhredin
Francesca Granata
Elena Cassinerio
Marco Maggioni
Anna Ludovica Fracanzani
Maria Domenica Cappellini
Irene Motta
Publication date
03-01-2024
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 3/2024
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-023-05591-x

Other articles of this Issue 3/2024

Annals of Hematology 3/2024 Go to the issue

Original Article

Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study

Letter to the Editor

Refractory hemophagocytic lymphohistiocytosis secondary to polatuzumab vedotin plus rituximab and bendamustine

Original Article

Diffuse large B cell lymphoma characteristics and outcomes during the COVID-19 pandemic in two tertiary centers - an Israeli/ Italian study

Original Article

Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial

Original Article

NOTCH pathway mutation contributes to inferior prognosis in HBV-infected chronic lymphocytic leukemia

Original Article

Efficacy and safety of biosimilar Peg-filgrastim after autologous stem cell transplant in myeloma and lymphoma patients: a comparative study with biosimilar Filgrastim, Lenograstim, and originator Peg-filgrastim
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits